Sang-In Yang

Title: **Inventor Sang-In Yang and His Breakthrough in Anemia Treatment**

Introduction

Sang-In Yang, located in Daegu, South Korea, is an innovative inventor in the field of medical treatments, particularly known for his work on a long-acting EPO formulation. With a total of one patent to his name, Yang has made significant contributions to the treatment of anemia, enhancing the effectiveness and safety of existing medical therapies.

Latest Patents

Yang’s notable patent is titled "Method of treating anemia using long-acting EPO formulation." This invention focuses on a groundbreaking method for administering a fusion polypeptide that combines Erythropoietin (EPO) with an immunoglobulin hybrid Fc. This formulation demonstrates a safer and longer-acting property compared to existing EPO products. Moreover, it seeks to minimize the cardiovascular side effects that are often associated with rapid increases in hemoglobin levels during anemia treatment.

Career Highlights

Throughout his career, Sang-In Yang has worked with renowned companies, including Genexine, Inc., and The Green Cross Corporation. His experienced background in these organizations has further honed his skills and knowledge in medical innovations and research, particularly in hematological treatments.

Collaborations

Yang has collaborated with talented individuals such as Jung-Won Woo and Se Hwan Yang. These professional relationships have undoubtedly contributed to the advancement of his inventions and the successful development of his patent.

Conclusion

In summary, Sang-In Yang is a notable inventor whose patented method for treating anemia highlights his commitment to improving patient care. His innovative approach not only offers an effective treatment option but also emphasizes safety by reducing potential side effects. Yang's contributions to the medical field continue to inspire advancements in anemia therapies, showcasing the importance of innovation in healthcare.